NEW YORK (GenomeWeb) – Veracyte announced today that Medicare contractor Palmetto GBA has issued a draft local coverage determination (LCD) for the company's Percepta Bronchial Genomic Classifier.

"As anticipated, we are moving quickly toward securing draft Percepta LCDs from all four [Molecular Diagnostic Services] program participants," Veracyte President and CEO Bonnie Anderson said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.